The Daily Bolus: The Triple Agonist Showdown & Surprising GLP-1 Wins in Type 1 Diabetes

Welcome to today s edition of The Daily Bolus! The incretin landscape is rapidly evolving into the era of the triple agonist, with Eli Lilly and [...]